In September, we will be inviting eligible patients for the Respiratory Syncytial Virus (RSV) vaccine. See below for the eligibility criteria:
-
Turn 75 years of age on or after 1 September 2024.
-
Already be aged between 75 and 79 years old on 1 September 2024.
What is RSV? Respiratory Syncytial Virus (RSV) is an infectious disease of the airways and lungs. RSV infection often causes symptoms similar to a cold, including cough, sore throat, sneezing and runny or blocked nose. It can also make you become wheezy or short of breath and lead to pneumonia and other life threatening conditions. There is no specific treatment, and most infections will get better by themselves. Every year thousands of older adults need hospital care for RSV, and some of them will die. RSV can be more severe in people with medical conditions such as heart or lung disease or a weakened immune system. RSV infection is common in young children but is most serious for small babies and for older people
For more information, please click on the leaflet attached assets.publishing.service.gov.uk (PDF)